Skip to main content

SG STOCKS PICK

Search This Blog

Neo Group has hit 42cts

Get link
Facebook
X
Pinterest
Email
Other Apps

Neo Group has hit 42cts which is close to my target of 45 cts.

I will be exiting position on Neo Group.

Get link
Facebook
X
Pinterest
Email
Other Apps

Comments

Popular Posts

Singapore Kitchen Equipment Ltd: Brewing a nice dish for shareholders !

Singapore Kitchen(SKE) was listed on SGX in 2013 at a price of 20cts. It has hit a high of 25cts on 19th June 2014, a low of 7.3cts in early 2016. Investment Merits: 1) Company has only $0.4 million of long term debt vs a net cash position. 2) 2 main segment of business: 1) Distribution & Fabrication of kitchen equipment 2) Maintenance & Servicing: Abt 75% of revenue is accounted for Distribution & Fabrication of kitchen equipment, with 25% of revenue as recurring income. As years go by, i am sure the recurring revenue will keep increasing. 3) With robotic machinery, the product can automated and increase efficiency in kitchens. This may be a stepping stone for SKE to widen its client base. 4) Profit has grown from $0.11 million upon listing to $2.57 million in FY2016. Its ROA and ROE is 11.75% and 17% respectively. In the last 4 years of listing, SKE has slowly growing. 5) Decent dividend yield of 4.69% base on last traded price of 16cts. 6) Single digit PE o...

Metal Companies listed on SGX: A relook ?

Listed on SGX, there are various companies dealing with Metals trading. Lets take a look at the following companies: 1) BRC Asia 2) Asia Enterprises Holding 3) Hup Steel 4) Lee Metal 5) HG Metal These 5 companies have business primarily in Singapore. With the stabilizing prices in commodities, these few companies are worth a re-look. Personally i like HG Metal. It is trading at 0.63x its book value, and commanding a dividend of 7.5% at at price of 8cts. Lee Metal and BRC Asia is trading close to its book value, whereas Hupsteel is trading at 0.58x.

STAR PHARMACEUTICAL LIMITED: A Star in SGX ?

STAR Pharmaceutical Limited is an investment holding company. The principal activities of the subsidiaries are those relating to the development, manufacturing and trading of pharmaceutical products. The Company operates in the development, manufacturing and trading of pharmaceutical products segment. The Company and its subsidiaries are engaged in the manufacture and sale of both western and Traditional Chinese Medicine (TCM)-formulated prescription drugs. The Company's range of pharmaceutical products include antibiotics, cerebrovascular drugs and cardiovascular drugs, and other specialized drugs manufactured in-house in various dosages and administration forms from powder injections, lyophilized powder injections, liquid injections to tablets, capsules and granules. It has approximately 820 distributors to hospitals, clinics and pharmacies. The Company has a manufacturing facility based in Qionghai City, Hainan Province of People's Republic of China. ( Taken from Thomso...

Powered by Blogger